ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

As a global leader in model-informed drug development and quantitative science, Certara was proud to be at the forefront of these conversations, demonstrating how our integrated ecosystem of technologies and consulting expertise drives smarter, faster development decisions.

Our collective presence included:

• Two major product launches: Certara IQ™ and Phoenix® Cloud
• Hands on workshops: Deep dives into Quantitative Systems Pharmacology (QSP) and Model Based Meta Analysis (MBMA)
• Participation in four scientific sessions across key therapeutic areas
• 18 posters highlighting the latest in exposure response modeling, radiopharmaceuticals, gene therapy, machine learning, and trial design

Together, these engagements showcased how Certara helps our partners make confident, data-driven decisions that move science and treatments forward.

A special highlight was celebrating Professor Amin Rostami Hodjegan, recipient of the prestigious Lewis B. Sheiner Award, recognizing his outstanding contributions and visionary leadership that continue to shape the field of pharmacometrics research worldwide.

Our QSP Workshop featuring Certara IQ was a huge success, with every seat taken. Attendees were eager to see firsthand how this revolutionary platform is transforming QSP modeling at scale. Equally exciting was our MBMA Session which drew standing room only crowds eager to explore first-hand some detailed applications of MBMA using case studies. Both sessions proved how scalable biosimulation can improve model transparency, enhance collaboration, and accelerate clinical insight generation.

Attendees engaged in interactive demos and discussions, highlighting real world case studies and learning how Certara’s integrated platforms streamline workflows across disciplines.

Building on the excitement of ACoP, we officially launched Certara IQ, a next generation AI-enabled QSP platform designed to make QSP modeling faster, more collaborative, and accessible at scale.

With cloud-based performance, a library of pre-validated QSP models, and automated biological modeling workflows, Certara IQ bridges the gap between science and computation, empowering teams to deliver insight at the speed of innovation. Interest in this revolutionary QSP modeling software skyrocketed, reaffirming its position as the leading AI-enabled software powering the next generation of model-informed drug development.

As the ACoP community continues to push boundaries in MIDD, Certara remains committed to enabling the next generation of quantitative scientists, equipping them with the tools, technology, and training to model with confidence and impact global health outcomes.